Form 8-K - Current report:
SEC Accession No. 0001437749-23-008429
Filing Date
2023-03-29
Accepted
2023-03-29 16:32:55
Documents
15
Period of Report
2023-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20221121_8k.htm   iXBRL 8-K 28170
2 EXHIBIT 99.1 ex_449725.htm EX-99.1 154272
7 dyadic.jpg GRAPHIC 4271
  Complete submission text file 0001437749-23-008429.txt   339891

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20230329.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20230329_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20230329_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20230329_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT dyai20221121_8k_htm.xml XML 2575
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 23775666
SIC: 2836 Biological Products, (No Diagnostic Substances)